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The membrane oxygenator has replaced the bubble was capable of binding 130 ng fentanyl/cm* mem- 
oxygenator in a wide variety of clinical settings. The brane. When presented with a smeller concentration 
membrane oxygenators now manufactured can be (520 ng/mL) of fentanyl, the membrane was able to 
grouped into three categories based on composition extract all available fentanyl from solution. All of the 
and design: (1) silicone with a true membrane struc- microporous polypropylene oxygenators (types 2 
ture; (2) polypropylene with a microporous sheet; and 3) absorbed significantly less fentanyl than did 
and (3) polypropylene with a microtubular structure. the SciMed brand. When exposed to 10 or 20 ng/mL, 
The capacity for fentanyl uptake by membrane oxy- the Shiley and Omnis brands (type 2) absorbed 0.1 
genators from these three categories was studied in and 0.4 ng/cm2. respectively. Using the higher fenta- 
vitro. Representative membrane samples were incu- nyl concentrations (~200 ng/mL) uptake by the 
bated in solutions containing tritiated fentanyl in Omnis membrane was 11 ng/cm’ compared with 
Normosol-R (Abbott, North Chicago, IL) with pH only 2 nglcm’ by the Shiley. The Bentley BCM 7 and 
adjusted to 7.4 at 37°C. Fentanyl analysis was per- Terumo Capiox II 08 microtubular microporous mem- 
formed using liquid scintillation and redioimmunoas- branes (type 3) did not show absorption of fentanyl 
say techniques. The uptake of fentanyl at various using isolated or intact membrane models. It is 
concentrations (340 to 10 ng/mL) was studied. The concluded that oxygenators of different design and/ 
SciMed (type 1; SciMed, Minneapolis, MN1 mem- or composition have different capacities for fentanyl 
brane showed the greatest capacity for fentanyl uptake. 
uptake at all concentrations. The SciMed oxygenator 0 1990 by W.B. Saunders Company. 
LTERATIONS IN plasma fentanyl levels A with the initiation of cardiopulmonary by- 
pass (CPB) have been appreciated for the past 
decade.’ Previous clinical studies describe de- 
creases in plasma fentanyl concentrations rang- 
ing from 20% to 75% during CPB.‘-’ Many early 
reports explain the change in fentanyl concentra- 
tion as a result of hemodilution.‘-3 However, 
other investigators have reported a decrease in 
fentanyl concentration in excess of that expected 
by dilution alone. 4-6 Furthermore, laboratory stud- 
ies report a loss of fentanyl from the isolated 
circulating CPB circuit used in vitro.53738 
Despite widespread recognition of the alter- 
ation of fentanyl pharmacokinetics by CPB, 
there is a great quantitative variation in the data 
available from previous clinical reports. Many 
important physiological variables were not con- 
trolled in these clinical studies, including temper- 
ature, pH, protein content, fentanyl dose, and 
delivery regimen, all of which have the potential 
to modify fentanyl pharmacokinetics. The types 
of CPB circuits in these reports were, likewise, 
not uniform. In many studies, the type and brand 
of CPB equipment was not stated.2,39699 A bubble 
oxygenator was used in three clinical studies’,4*‘0 
and in one in vitro study7; however, the oxygen- 
ator manufacturer was the same in only two of 
these reports.‘,” Koren et al’ used a membrane 
oxygenator in both the in vivo and in vitro phases 
of their study. The oxygenator has been noted to 
be the major site of fentanyl uptake by the CPB 
circuit5*7*8*1i for both membrane and bubble oxy- 
genators. Differences in CPB circuitry, specifi- 
cally the oxygenator, may be responsible for a 
large portion of the variability in previous clinical 
studies. The purpose of this study was to compare 
five different membrane oxygenators in vitro 
under controlled conditions for fentanyl uptake 
using a previously validated technique. 
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Five different membranes were studied: SciMed 3500- 
2A, Shiley M-2000 (Irvine, CA), Omnis LPM 50 (Deerfield, 
IL), Bentley BCM 7 (Irvine, CA), and Terumo Capiox II 08 
(Tokyo, Japan). The SciMed, Shiley, and Omnis all have a 
sheet structure, whereas the Bentley and Terumo have a 
microtubular structure (Table 1). Fentanyl analysis in the 
isolated membrane studies was performed by liquid scintilla- 
tion counting in the manner previously described.’ Radioim- 
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Table 1, Structure and Composition of Membranes 
Studied 
mg of fentanyl was added to the circulating prime. Samples 
for fentanyl analysis were then obtained at 5, 10, 20, 30,40, 
50, and 60 minutes after fentanyl exposure. 
























munoassay (RIA) performed by Analytical Technologies 
(Tempe, AZ) was performed to follow fentanyl concentra- 
tions in the intact circuit studies. In prior studies of a sheet 
membrane oxygenator,’ the characteristics of fentanyl up- 
take in the isolated circuit have been shown to correlate with 
uptake in the intact circuit. Therefore, only the microtubular 
membranes were studied in the intact circuit in the present 
study. All experiments were performed at 22%. 
Isolated Sheet Membrane Studies 
The intact sheet structure membranes were dissected 
to expose the membrane material. Thirty-two 1 x l-cm 
squares of the membrane were randomly obtained from the 
three oxygenators with a sheet structure. Each membrane 
sample was weighed before exposure to fentanyl. Using the 
membrane density supplied by the manufacturer, the surface 
area was calculated. A balanced salt solution (Normosol-R, 
Abbott Laboratories, North Chicago, IL) containing triti- 
ated fentanyl was prepared, with the pH adjusted to 7.4, at 
37%; the solution had a total fentanyl concentration of 340 
ng/mL. For the three oxygenators with a sheet structure, 1 
mL of the fentanyl solution was then placed in each of 96 test 
tubes. A single membrane square was added to each test tube. 
Two membrane samples of each oxygenator brand were 
removed from the solution at each sample time. A sample 
pair was removed immediately after immersion, and then 
every 15 minutes for 3.5 hours. After removal from the 
solution, the membrane squares were rinsed with distilled 
water and dried. The experiment was performed at a room 
temperature of 22“C. The experiment was then performed 
with decreasing fentanyl concentrations of 255, 200,20, and 
10 ng/mL. 
Intact Circuit Microtubular Membrane Studies 
A circuit was assembled for each oxygenator using a 
bubble trap, polyvinyl chloride (PVC) tubing, and the mem- 
brane oxygenator. The CPB circuit was primed with Normo- 
sol-R, with pH adjusted to 7.4, at 37°C. The priming volume 
in the Terumo Capiox II 08 CPB circuit was 225 mL. Flow 
was maintained at 0.8 L/min. The Bentley BCM 7 CPB 
circuit circulating volume was 315 mL, and flow was main- 
tained at 2 L/min. A control sample was obtained, and then 1 
Isolated Microtubular Membrane Studies 
One membrane of each brand was dissected to expose 
the membrane material. Two random samples of microtu- 
bules, approximating 1 cm* of surface area, were obtained 
from each membrane. Three milliliters of tritiated fentanyl in 
Normosol-R solution, adjusted to pH 7.4, at 37OC, was placed 
into each of 4 tubes. The starting fentanyl concentration was 
200 ng/mL. Control samples were obtained before the 
addition of the membrane material. The microtubules were 
then added, and the tubes were agitated. Ten-microliter 
aliquots of solution were removed for fentanyl analysis every 
15 minutes for 2.5 hours. This experiment was performed at 
22oc. 
RESULTS 
The five membranes tested showed a re- 
markably different capacity for fentanyl uptake. 
The fentanyl concentrations greater than 200 
ng/mL were all adequate to produce saturation 
of all 5 brands. There was no difference in 
fentanyl uptake by any of the membranes as a 
function of fentanyl concentration in this range 
(200 to 340 ng/mL). The ratio of fentanyl 
uptake for the membranes with a sheet structure 
was approximately 100: 10: 1 for the SciMed, 
Omnis, and Shiley membranes, respectively (Ta- 
ble 2). As in previous studies,” the SciMed 
membrane became saturated at 130 ng/cm*. The 
Shiley membrane showed the least affinity for 
fentanyl; less than 1% of the fentanyl in solution 
was absorbed by this brand. The degree of 
fentanyl uptake by the Omnis membrane was 
between those of the other two models but much 
closer to that of the Shiley membrane. 
Using fentanyl concentrations more like 
those achieved in clinical practice (10 and 20 
ng/mL), the SciMed membrane was able to 
extract all the fentanyl available from the solu- 
tion. The Shiley membrane absorbed only 0.1 
ng/cm* in either the 10 or 20 ng/mL solutions. 
Fentanyl uptake by the Omnis membrane was 
also reduced to only 0.4 ng/cm*. 
Table 2. Fentanyl Uptake for Different Membranes 
Fentanyl 
Maximum Fentanyl Uptake 
Concenaation Ing/cm’l 
(ng/mL) SciMed Shiley Omnis Bentley Terumo 
10 10 0.1 0.4 - - 
20 20 0.1 0.4 - - 
,200 130 2 11 0 0 
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For the membranes with the microtubular 
structure (Bentley and Terumo), no uptake of 
fentanyl by the membrane could be shown in 
either the intact or isolated membrane at any 
concentration. 
DISCUSSION 
The present data show a marked variability 
in the capacity for fentanyl uptake by five dif- 
ferent membrane oxygenators in vitro. In the 
absence of hemodilution and other clinically 
variable parameters such as pH, protein content, 
duration of prebypass, hematocrit, drug interac- 
tions, fentanyl dose, patient pharmacokinetics, 
surgery and anesthesia, the affinity of different 
apparatuses alone for fentanyl can be compared. 
The tremendous capacity for fentanyl uptake by 
the SciMed brand was again shown to be 130 
ng/cm* as in a previous study.’ Although the two 
polypropylene microporous membrane oxygen- 
ators showed much less affinity for this opiate, 
the microtubular membranes did not bind any 
fentanyl under the experimental conditions. Clin- 
ically, this could be extrapolated to adult mem- 
branes: SciMed model 3500-2A, with a surface 
area of 3.5 m*, would bind 4.55 mg; the Omnis, 
with a surface area of 3 m*, would bind 0.33 mg; 
and the Shiley, with a surface area of 2 m*, would 
bind 0.04 mg. 
Fentanyl pharmacokinetics are modified by 
CPB. Early reports explained the precipitous 
decrease in plasma fentanyl concentrations by 
hemodilution or sequestration in the lung.‘” 
More recently, several studies have documented 
the concept of direct fentanyl uptake by the 
oxygenator of the cardiopulmonary bypass 
circuit.5,7*‘1 Most early studies of fentanyl uptake 
and CPB equipment used bubble oxygenators or 
did not state circuit composition. Application of 
fentanyl pharmacokinetic data derived from bub- 
ble oxygenators to these new CPB membrane 
systems may not be valid. The newer membrane 
oxygenators are becoming more popular in clini- 
cal practice for a variety of reasons: efficiency of 
gas exchange; less damage to blood components; 
size; integration of heat exchangers; and durabil- 
ity. Clinical studies suggest that membrane oxy- 
genators can produce a much greater alteration 
(75% reduction in circulating fentany15q6) in 
plasma level than the bubble oxygenator (30% to 
50% reduction in circulating fentanyl).‘*2~4*‘o One 
study using a membrane oxygenator noted fen- 
tanyl levels below the level associated with 
awakening.6 
This report suggests that the differences in 
fentanyl uptake may be explained by variations 
in CPB circuit and oxygenator structure and 
composition. The membranes studied are repre- 
sentative of the three major designs in modern 
membrane oxygenators. The SciMed membrane 
oxygenator is a solid membrane sheet without 
pores. Membranes in the other four oxygenators 
have a microporous structure in the form of 
either a sheet or microtubules. Membrane mate- 
rials also vary. The SciMed oxygenator is made 
of a silicone rubber sheet impregnated with 
Dacron fibers. The Shiley, Omnis, Bentley, and 
Terumo membrane oxygenators are made of 
polypropylene. The Omnis membrane has a dou- 
ble layer of polypropylene, whereas the Shiley 
membrane has a single layer. This may account 
for the differences in absorptive capacities be- 
tween the two. The microtubular design has 
recently become available from Bentley and 
Terumo. The advantage of the microtubular 
design is the improved efficiency of gas exchange 
and small priming volumes compared with the 
other microporous oxygenators. 
In vitro, both siliconized tubing and silicone- 
containing oxygenators have been shown to bind 
fentanyl.5~8 Even the SciMed oxygenator’s sili- 
cone watertight wrapper (which has no role in 
gas exchange) can bind fentanyl.’ It is hypothe- 
sized that the silicone is responsible for greater 
fentanyl affinity in the SciMed oxygenator and 
that the silicone products may have a large 
affinity for other lipophilic anesthetics. Silicone is 
also frequently used in the defoamer and may be 
the major site of fentanyl uptake in bubble 
oxygenators. One in vitro study using a bubble 
oxygenator described a larger decrease in fenta- 
nyl concentration than previous reports of bubble 
oxygenators,’ but the circuit was assembled us- 
ing silicone tubing. PVC tubing has been shown 
to be inert to fentanyl.5*6 
The SciMed’s tremendous uptake capacity 
for fentanyl poses the greatest potential for the 
development of subtherapeutic (~20 ng/mL) 
fentanyl concentrations. Despite a lo- to lOO- 
fold increase in fentanyl-absorptive capacities 
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compared with the polypropylene designs, there 
are advantages to the silicone sheet design. Only 
the SciMed membrane oxygenator has been 
approved for such long-term use as extracorpo- 
real membrane oxygenation. The microporous 
designs are frequently associated with decreased 
efficiency (leaking or plugging) after prolonged 
usage. The SciMed membrane oxygenator is also 
available in a greater variety of sizes so that the 
patient’s oxygen requirement may be more closely 
matched with the membrane surface area and 
circuit size, thereby allowing the use of a mini- 
mal priming volume. 
showed a larger capacity for fentanyl uptake 
than the Shiley. However, the fentanyl uptake 
was still only 11 ng/cm*. The two microporous 
microtubular membranes seem to be practically 
inert to fentanyl. Any decrease in fentanyl levels 
when these oxygenators are placed in a nonsili- 
cone circuit should be explainable on the basis of 
dilution alone. 
In summary, this study has shown the 
differential capacity for absorption of fentanyl by 
five different membrane oxygenators. The absorp- 
tive capacity seems to be related to its composi- 
tion and structural design. The silicone SciMed 
has a much larger affinity for fentanyl both at 
clinical concentrations and at concentrations 
above that required for membrane saturation. 
The capacity for fentanyl uptake by the polypro- 
pylene membranes was minimal (0.5% to 4%) at 
clinical fentanyl concentrations. At very high 
fentanyl levels (200 to 340 mg/mL), the Omnis 
Further investigation is necessary to exam- 
ine the interactions of the oxygenators with other 
anesthetic agents. There is a potential for any 
lipophilic drug to be taken up by silicone- 
containing oxygenators. Following clarification 
of the in vitro characteristics, further studies 
must be performed to determine any modifica- 
tion by clinically relevant variables in the fen- 
tanyl-membrane interaction. 
In conclusion, there is a need for greater 
awareness about CPB circuit composition. This 
study has identified one variable, fentanyl up- 
take, that is significantly altered as a function of 
the apparatus alone. Most important, CPB cir- 
cuits must be individually examined for drug 
interactions. 
REFERENCES 
1. Lunn JK, Stanley TH, Eisele J, et al: High-dose 
fentanyl anesthesia for coronary artery surgery: Plasma 
fentanvl concentrations and influence of nitrous oxide on 
cardiovascular responses. Anesth Analg 58:390-3951979 
2. Bentley JB, Conahan TJ, Cork RC: Fentanyl 
sequestration in lungs during cardiopulmonary bypass. Clin 
Pharmacol Ther 34:703-706, 1983 
7. Skacel M, Knott C, Reynolds F, Aps C: Extracor- 
poreal circuit sequestration of fentanyl and alfentanil. Br J 
Anaesth 58:947-949.1986 
8. Rosen D, Rosen K, Davidson B, Broadman L: 
Fentanyl Uptake by the SciMed membrane oxygenator. J 
Cardiothorac Anesth 2:619-626, 1988 
3. Wynands JE, Townsend GE, Wong P, et al: Blood 
pressure response and plasma fentanyl concentrations during 
high- and very high-dose fentanyl anesthesia for coronary 
artery surgery. Anesth Analg 62:661-665, 1983 
4. Bovill JG, Sebel PS: Pharmacokinetics of high- 
dose fentanyl. Br J Anaesth 52:795-801, 1980 
5. Koren G, Crean P, Klein J, et al: Sequestration of 
fentanyl by the cardiopulmonary bypass. Eur J Clin Pharma- 
co1 27:51-56, 1984 
9. Koska AJ, Romagnoli A, Kramer WG: Effect of 
cardiopulmonary bypass on fentanyl distribution and elimina- 
tion. Clin Pharmacol Ther 29: 100-105, 198 1 
10. Hynynen M, Takkunen 0, Salmenpera M, et al: 
Continuous infusion of fentanyl or alfentanil for coronary 
artery surgery. Plasma opiate concentrations, haemodynam- 
its, and postoperative course. Br J Anaesth 58:1252-1259, 
1986 
6. Koren G, Goresky G, Crean P, et al: Pediatric 
fentanyl dosing based on pharmacokinetics during cardiac 
surgery. Anesth Analg 63:577-582,1984 
11. Koren G, Crean P, Goresky G, et al: Irreversible 
binding of fentanyl to the cardiopulmonary bypass. Anesth 
Analg 63:236, 1984 
